Sterilizing Activities of Novel Combinations Lacking First- and Second-Line Drugs in a Murine Model of Tuberculosis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sterilizing Activities of Novel Combinations Lacking First- and Second-Line Drugs in a Murine Model of Tuberculosis
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 56, Issue 6, Pages 3114-3120
Publisher
American Society for Microbiology
Online
2012-04-03
DOI
10.1128/aac.00384-12
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis [Short communication]
- (2012) C. Pierre-Audigier et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Rapid Evaluation in Whole Blood Culture of Regimens for XDR-TB Containing PNU-100480 (Sutezolid), TMC207, PA-824, SQ109, and Pyrazinamide
- (2012) Robert S. Wallis et al. PLoS One
- Short-Course Chemotherapy with TMC207 and Rifapentine in a Murine Model of Latent Tuberculosis Infection
- (2011) Tianyu Zhang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Clofazimine Analogs with Efficacy against Experimental Tuberculosis and Reduced Potential for Accumulation
- (2011) Yu Lu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pyrazinoic Acid Decreases the Proton Motive Force, Respiratory ATP Synthesis Activity, and Cellular ATP Levels
- (2011) Ping Lu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sterilizing Activity of Novel TMC207- and PA-824-Containing Regimens in a Murine Model of Tuberculosis
- (2011) Rokeya Tasneen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Susceptibility of ClinicalMycobacterium tuberculosisIsolates to a Potentially Less Toxic Derivate of Linezolid, PNU-100480
- (2011) J. W. C. Alffenaar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Importance of Confirming Data on theIn VivoEfficacy of Novel Antibacterial Drug Regimens against Various Strains of Mycobacterium tuberculosis
- (2011) Mary A. De Groote et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of TMC207 and ItsN-Desmethyl Metabolite in a Murine Model of Tuberculosis
- (2011) Marie-Claude Rouan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Course of murine tuberculosis and response to first-line therapy depends on route of infection and inoculum size
- (2011) J.E.M. de Steenwinkel et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Patterns of pncA mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea
- (2011) H. J. Kim et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal models
- (2011) Z. Ahmad et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Mouse Model of Necrotic Tuberculosis Granulomas Develops Hypoxic Lesions
- (2011) Jamie Harper et al. JOURNAL OF INFECTIOUS DISEASES
- Location of Intra- and Extracellular M. tuberculosis Populations in Lungs of Mice and Guinea Pigs during Disease Progression and after Drug Treatment
- (2011) Donald R. Hoff et al. PLoS One
- Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
- (2010) Armand Van Deun et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Comparative Studies Evaluating Mouse Models Used for Efficacy Testing of Experimental Drugs againstMycobacterium tuberculosis
- (2010) Mary A. De Groote et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for Tuberculosis
- (2010) Robert S. Wallis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Reduction of Clofazimine by Mycobacterial Type 2 NADH:Quinone Oxidoreductase
- (2010) Takahiro Yano et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pharmacokinetics and Whole‐Blood Bactericidal Activity againstMycobacterium tuberculosisof Single Doses of PNU‐100480 in Healthy Volunteers
- (2010) Robert S. Wallis et al. JOURNAL OF INFECTIOUS DISEASES
- Sterilizing Activity of R207910 (TMC207)-containing Regimens in the Murine Model of Tuberculosis
- (2009) Murad Ibrahim et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Addition of PNU-100480 to First-Line Drugs Shortens the Time Needed to Cure Murine Tuberculosis
- (2009) Kathy N. Williams et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Noninvasive Pulmonary [18F]-2-Fluoro-Deoxy-D-Glucose Positron Emission Tomography Correlates with Bactericidal Activity of Tuberculosis Drug Treatment
- (2009) S. L. Davis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial
- (2009) Marcus B Conde et al. LANCET
- The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
- (2009) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Isoniazid or Moxifloxacin in Rifapentine-based Regimens for Experimental Tuberculosis?
- (2008) Ian M. Rosenthal et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model
- (2008) K. N. Williams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Enhanced Bactericidal Activity of Rifampin and/or Pyrazinamide When Combined with PA-824 in a Murine Model of Tuberculosis
- (2008) R. Tasneen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis
- (2008) E. Nuermberger et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prevention of Drug Carryover Effects in Studies Assessing Antimycobacterial Efficacy of TMC207
- (2008) N. Lounis et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Pyrazinamide Resistance among South African Multidrug-Resistant Mycobacterium tuberculosis Isolates
- (2008) M. Mphahlele et al. JOURNAL OF CLINICAL MICROBIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now